Invention Grant
- Patent Title: Protein and peptide-free synthetic vaccines against Streptococcus pneumoniae type 3
-
Application No.: US15022708Application Date: 2014-09-18
-
Publication No.: US10052373B2Publication Date: 2018-08-21
- Inventor: Dominea Rathwell , Sharavathi Guddehalli Parameswarappa , Subramanian Govindan , Chakkumkal Anish , Claney Lebev Pereira , Peter H. Seeberger , Felix Bröcker
- Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
- Applicant Address: DE Munich
- Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Current Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Current Assignee Address: DE Munich
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: EP13185039 20130918
- International Application: PCT/EP2014/069947 WO 20140918
- International Announcement: WO2015/040140 WO 20150326
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61K47/54 ; A61K47/55 ; A61K47/61 ; A61K39/00
Abstract:
The present invention provides a protein- and peptide-free conjugate comprising a synthetic carbohydrate and a carrier molecule, wherein the synthetic carbohydrate is a Streptococcus pneumoniae type 3 capsular polysaccharide related carbohydrate and the carrier molecule is a glycosphingolipid. Said conjugate and pharmaceutical composition thereof are useful for immunization against diseases associated with Streptococcus pneumoniae, and more specifically against diseases associated with Streptococcus pneumoniae type 3.
Public/Granted literature
- US20160279224A1 PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 Public/Granted day:2016-09-29
Information query
